Morse Asset Management’s Medpace MEDP Stock Holding History

Morse Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,340	Closed	-$552K	–	347
2024 Q2	$552K	Buy	+1,340	New	+$531K	0.13%	111

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morse Asset Management's MEDP Position: Q3 2024 in Review

Morse Asset Management sold out of Medpace (MEDP) in Q3 2024, closing a stake of 1,340 shares — an estimated $552K sold.

Morse Asset Management first reported a position in MEDP in Q2 2024 and held it in 1 quarter. The position peaked at $552K in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

Morse Asset Management reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
Morse Asset Management sold 1,340 Medpace shares in Q3 2024, an estimated $552K.
Morse Asset Management first reported a position in Medpace in Q2 2024 and held it in 1 quarter.
Morse Asset Management's Medpace position peaked at $552K in Q2 2024.
583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Morse Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.